Jazz Pharmaceuticals plc (JAZZ): Share Repurchases
$125.02M
Year ended 2025-12-31
n/m
3-year compound annual growth
-3.1%
5-year compound annual growth
+7.3%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $125.02M | -59.9% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $311.43M | +15.4% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $269.76M | n/m | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $54.0K | n/a | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $0 | -100.0% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $146.54M | -51.4% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $301.45M | -42.4% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $523.67M | +430.0% | 2021-02-23, From 2018-01-01 |
| 2017-12-31 | $98.80M | -64.5% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $278.30M | +352.1% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $61.55M | +45.8% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $42.22M | -69.1% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $136.48M | n/a | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $0 | n/a | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $0 | n/a | 2014-02-25, From 2011-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.00B | 0.0% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.23B | +434.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.01M | n/a |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.23B | +74.1% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $2.02B | +71.4% |
| Alkermes plc. (ALKS) | 2024-12-31 | $200.28M | n/a |
| Viatris Inc (VTRS) | 2025-12-31 | $500.50M | +100.2% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
Compare JAZZ, UTHR, RPRX, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗